Nuzhat Pathan Selected Research

Nuzhat Pathan Research Topics

6	Neoplasms (Cancer) 02/2024 - 03/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2016
3	Melanoma (Melanoma, Malignant) 02/2024 - 01/2017
2	Triple Negative Breast Neoplasms 01/2023 - 01/2023
1	Diarrhea 02/2024
1	Vomiting 02/2024
1	Skin Neoplasms (Skin Cancer) 02/2024
1	Nausea 02/2024
1	Lung Neoplasms (Lung Cancer) 02/2024
1	Fatigue 02/2024
1	Ovarian Neoplasms (Ovarian Cancer) 12/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2017
1	Endometrial Neoplasms (Endometrial Cancer) 12/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Ischemia 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Pulmonary Arterial Hypertension 01/2017
1	Right Ventricular Hypertrophy 01/2017

3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2017
3	gedatolisibIBA 01/2023 - 12/2017
2	encorafenibIBA 02/2024 - 01/2023
2	binimetinibIBA 02/2024 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 07/2022 - 03/2016
2	mirdametinibIBA 12/2017 - 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	dacomitinibIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Tyrosine Kinase InhibitorsIBA 07/2022
1	palbociclibIBA 07/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2017
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 12/2017
1	MTOR InhibitorsIBA 12/2017
1	Immunoglobulin G (IgG)IBA 09/2017
1	pembrolizumabIBA 09/2017
1	utomilumabIBA 09/2017
1	peginterferon beta-1aIBA 01/2017
1	InterferonsIBA 01/2017
1	Serotonin ReceptorsIBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	nazartinibIBA 03/2016

2	Therapeutics 01/2017 - 03/2016